Delivery Order SPE2DB22D6029-SPE2DB25FLVHB

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,643.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CYANOKIT 5 gram vials, a pharmaceutical product, with a period of performance through July 9, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.85 firm-fixed-price delivery order is for CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has an ultimate completion date of July 1, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,643.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D2211|SPE2DB25FRWAB) for 4,568,053,685 units of the CYANOKIT 5 GRAM VIALS medical product, with a performance period extending through April 29, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of CYANOKIT 5 gram vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,964.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of March 14, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,982.31, is a Delivery Order under the Defense Logistics Agency (DLA) for the procurement of CYANOKIT 5 GRAM VIALS. The contract has an ultimate completion date of March 14, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is funded by the DLA, a defense agency....
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of 4564731120 CYANOKIT 5 gram vials. The contract has a ceiling value of $2,833.68 and is a Delivery Order with a Firm Fixed Price pricing type. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through May 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,625.39 firm fixed-price contract is for the delivery of CYANOKIT 5 gram vials, a specialty pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide CYANOKIT 5 gram vials. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $6,872.80. It is not a set-aside award. The contract has a firm-fixed price and an ultimate completion date of September 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOKIT 5 gram vials, with a ceiling value of $5,462.96 and a period of performance through July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $12,594.03 firm fixed-price delivery order is for the supply of CYANOKIT 5 gram vials, a medical product used to treat cyanide poisoning. The contract has an ultimate completion date of July 14, 2025 and does not utilize a set-aside designation, indicating open competition....
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLVHB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of CYANOKIT 5 gram vials. The $9,567.06 firm fixed-price delivery order has a completion date of June 17, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:43 AM